Prosecution Insights
Last updated: October 02, 2026

Examiner: ALABI, OYELEYE A

Tech Center 1700 • Art Units: 1651 1678 1758 1759 1797

This examiner grants 84% of resolved cases

Analysis

Oyeleye A Alabi is an examiner in Tech Center 1700, Art Unit 1651. The examiner has 275 resolved cases. The allowance rate for these cases is 84.0 percent. The median days to allowance is 1066, which is the time required for those cases to be granted. These figures offer a basis for evaluating prosecution strategies in this art unit.

The interview lift for this examiner is 25.2 percent. This figure shows the added probability of allowance associated with conducting an interview. The 25.2 percent lift is lower than the 84.0 percent allowance rate. With 275 resolved cases, the data provides a volume of outcomes for practitioners to analyze. The 1066 days to allowance serves as a benchmark for the duration of the prosecution process in Art Unit 1651. These figures assist in planning strategies for applications in Tech Center 1700.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

84.0%
Allow Rate
+19.0% vs TC avg
323
Total Applications
+25.2%
Interview Lift
1066
Avg Prosecution Days
Based on 275 resolved cases, 2023–2026

Rejection Statute Breakdown

6.5%
§101 Eligibility
24.7%
§102 Novelty
49.0%
§103 Obviousness
18.9%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18266770 FLUORESCENCE EVALUATION APPARATUSES, SYSTEMS, AND METHODS Non-Final OA Intuitive Surgical Operations, Inc.
18792286 SYSTEMS AND METHODS FOR PROVIDING FLUIDIC ACCESS TO A FLOW CELL Final Rejection LIFE TECHNOLOGIES CORPORATION
18517051 AUTOMATIC ANALYSIS DEVICE AND ABNORMALITY DETECTION METHOD Non-Final OA Canon Kabushiki Kaisha
18496642 DISINFECTANT VISUALIZATION SHEET, DISINFECTANT VISUALIZATION PARTICLE, DISINFECTANT VISUALIZATION METHOD USING SHEET OR PARTICLE, AND INFORMATION ACQUISITION SYSTEM Non-Final OA CANON KABUSHIKI KAISHA
18029210 METHODS TO DETERMINE RISK OF NEUROTOXICITY Final Rejection WASHINGTON UNIVERSITY
18290315 MARKER, METHOD AND DEVICE FOR ANALYZING A BIOLOGICAL SAMPLE Non-Final OA LEICA MICROSYSTEMS CMS GMBH
18207970 MULTI-PROTEIN CLASSIFIER FOR DETECTING EARLY-STAGE OVARIAN CANCER Non-Final OA REGENTS OF THE UNIVERSITY OF MINNESOTA
18541624 UNIVERSAL CALIBRATION FOR QUANTITATIVE MASS SPECTROMETRY Non-Final OA Roche Diagnostics Operations, Inc.
18175418 Method for Determining Medication Adherence and Taggants Therefo Final Rejection The Regents of the University of Colorado, A Body Corporate
18294617 URINE TESTING KIT Non-Final OA SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION
18495271 MICROFLUIDIC CHIP AND COSMETIC MANUFACTURING APPARATUS INCLUDING SAME Non-Final OA AMOREPACIFIC CORPORATION
18301056 REVERSE-PHASE HIGH PRESSURE LIQUID CHROMATOGRAPHY METHODS FOR MEASURING AMINO ACIDS, AMMONIUM, AND GLUTATHIONE CONCENTRATIONS IN BIOLOGICAL SAMPLES Non-Final OA CHILDREN'S NATIONAL MEDICAL CENTER
18250764 A HUMAN VASCULAR INJURY-ON-A-CHIP MODEL OF HEMOSTASIS Non-Final OA THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA
18259019 FOOD FRESHNESS DETECTING DEVICE AND METHODS FOR USING THE SAME Final Rejection UNIVERSITY OF MARYLAND, COLLEGE PARK
18682662 AN APPARATUS FOR A CELLULOSE-BASED VERTICAL FLOW ASSAY AND RELATED METHOD Non-Final OA Nanyang Technological University
18523636 FLOW CELLS WITH PASSIVATION COMPONENTS Non-Final OA ILLUMINA, INC.
18259105 MULTI-VOLUME MICROCHAMBER-BASED MICROFLUIDIC PLATFORM AND USE THEREOF Non-Final OA CORNELL UNIVERSITY
18259101 GRADIENT-BASED MICROFLUIDIC CIRCUIT, DEVICE, AND METHOD FOR PERFORMING AN ASSAY Non-Final OA CORNELL UNIVERSITY
18568538 LOW PH COMPOSITION AND METHOD FOR STABILIZING NUCLEIC ACIDS IN BIOLOGICAL SAMPLES Non-Final OA DNA Genotek Inc.
17678295 Relative Quantitation Using Electrochemical Mass Spectrometry Non-Final OA NEW JERSEY INSTITUTE OF TECHNOLOGY
18151161 POTASSIUM MALEATE BUFFER FOR FREE CHLORINE ANALYSIS Final Rejection HACH COMPANY
17782422 METHOD FOR ANALYZING DEGARELIX AND ASSOCIATED PRODUCTS Non-Final OA FRESENIUS KABI USA, LLC

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month